1. Introduction {#sec1}
===============

Anastomotic leakage (AL) after colectomy is one of the major complications in colorectal surgery. The incidence of AL ranges from 2% to 4% with proximal anastomosis to 6%--12% with distal extraperitoneal anastomosis [@bib1] and is associated with mortality rates of approximately 10% [@bib2], [@bib3]. However, incidence and mortality up of to 30% [@bib4], [@bib5] have been reported in rectal surgery. A combination of anatomical inaccessibility, less than optimal blood supply, tightly closed anal sphincter below an ultralow anastomosis and an infected pelvic hematoma are likely to be contributory factors. In addition, leakage after low anterior resection in patients with cancer may be associated with a higher local recurrence rate and a worse outcome [@bib6], [@bib7]. Consequently, several preliminary studies have been designed to investigate the role of transanal devices in the prevention of leakage. This technique has been proven to be comparable in the prevention of anastomotic failure, together with benefits of less surgical injury, avoidance of a second surgery, and finally, lower morbidity [@bib8], [@bib9], [@bib10].

The potential role of a transanal drainage tube (TDT) is supposed to be beneficial for the reduction of endoluminal pressure as well as fecal diversion, resulting in a protective effect on anastomotic healing. However, the majority of previous studies have been limited by a small sample size and use of a nonrandomized control group. In addition, the nonstandardized use of the technique, including the material used in the construction of the TDT, the shape of the tube, and the duration of its placement, has been reported. Moreover, inconsistent results were obtained in a retrospective study, which failed to prove the efficacy of the device [@bib11]. There has only been one prospective randomized controlled study, which demonstrated a benefit for the TDT with regard to the reduction of anastomotic bleeding and AL [@bib12]. Thus far, no study had shown an effect of a TDT on the severity of anastomotic leakage.

To further clarify the question of whether a TDT reduces the rate and severity of AL after colorectal anastomosis, we performed this retrospective study of prospectively collected data.

2. Material and methods {#sec2}
=======================

This retrospective study of prospectively collected data included all consecutive patients who were treated by surgery for benign or malign colorectal disease with colorectal anastomosis between January 2009 and December 2012 in our operative department. The study was performed according to the guidelines of the local ethic committee.

The following variables were analyzed: gender, age, mortality, ASA-score, hospital stay, surgical complications, medical complications, placement of TDT, malignancy, urgency of the procedure (emergency vs. semi-elective vs. elective), bowel preparation, operation technique (laparoscopic vs. open), abdominal drainage, endoscopic control of the anastomosis, diverting ileostomy, type of resection (anterior, low anterior, extended low anterior rectum resection), anastomotic technique (E/E vs. E/S vs. S/E vs. S/S), delayed anastomosis and anastomotic procedure (hand-sewn vs. stapled).

The following are criteria for the inclusion of patients in our study: colorectal anastomosis after resection of the sigmoid or rectum for benign or malign underlying disease \>18 years. Exclusion criteria were underlying gynecological disease as a reason for colorectal resection, Hartmann reversal operation, left-sided hemicolectomy and abdominoperineal resection.

For the purpose of this study, 242 patients were divided into two groups: the transanal drainage group (TD) and non-transanal drainage group (NTD), and we investigated whether a TDT was or was not used during the operation.

2.1. Surgical technique {#sec2.1}
-----------------------

The TDT was established as a routine clinical practice in December 2009 at our department. A 28 Charrière natural rubber latex foley catheter (Telefex Medical™) was inserted transanally immediately after the air leak test of the performed colorectostomy. It was placed between five and ten centimeters proximal to the anastomosis with visual or palpatory control and fixed using a 2-0 Vicryl™ perineal suture.

Every anastomosis, which was performed during a second-look operation after initial damage control surgery, was defined as delayed anastomosis. Loop ileostomy was selected for nearly all lower colorectal anastomosis below the peritoneal reflection in oncological surgery and routinely after neoadjuvant radiotherapy for rectal cancer.

2.2. Anastomotic leakage {#sec2.2}
------------------------

In the TD group, AL was defined as an extravasation observed by the radiologist in the routinely performed radiography on POD five with a contrast clyster. In the control group, AL was mostly (75%) confirmed using a CT scan, in cases where clinical signs, such as fever, severe abdominal pain, elevation of leukocytes and CRP or fecal delivery of the abdominal drain, occurred. In the CT scan, AL was proven in cases of air bubbles or edema with inflammatory reactions in the perianastomotic area.

We established a dehiscence score related to the size of the AL as the following: 1 = small dehiscence \<10 mm; 2 = medium dehiscence \>10 mm \<semi-circular; and 3 ≥ semi-circular.

Surgical and medical postoperative complications were classified as grade one to five according to Dindo et al. [@bib13].

The urgency of the procedure was categorized as an emergency (which indicated an immediate operation due to, e.g., free perforation with peritonitis), semi-elective (within seven days after admission due to, e.g., ineffective antibiotic treatment in diverticulitis) and elective surgery.

Oral bowel preparation with CleanPrep™ was performed when a loop ileostomy or intraoperative colonoscopy was planned. Rectal clysters were applied at the surgical ward before the patient was moved to the operation room in all other elective cases. No preparation was performed in the emergency procedures.

2.3. Statistical tests {#sec2.3}
----------------------

All statistical analysis was performed using SPSS Version 22.0 (International Business Machines Corporation, Armonk, NY). Continuous data are provided as the mean and standard deviation or the median and range. Dichotomous variables are represented as percentages. For group comparisons, either Fisher\'s exact or Chi-square tests were performed. All statistical tests were performed two-sided, and p-values \<0.05 were considered statistically significant. For the multivariate analysis, a linear regression analysis was performed using the backwards method.

3. Results {#sec3}
==========

In this study, 242 patients (103 (42.6%) female with a mean age of 63.5 (SD 14.3) years) were analyzed for the development of anastomotic leakage with a median hospital stay of 15 days. The hospital mortality rate was 1.2% (n = 3, myocardial infarction, AL, large bowel perforation).

The comparative demographic data, performed surgical techniques, underlying disease and complications between the interventional TD and the NTD groups are illustrated in [Table 1](#tbl1){ref-type="table"}.

The TDT was removed after a mean of 4.9 (SD 1.2) days. In 3 patients (2.2%), it was removed before postoperative day four, which caused the patients discomfort or perianal pain.

3.1. Anastomotic leakage rate {#sec3.1}
-----------------------------

In this study, 19 (7.9%) of the 242 patients developed an anastomotic leakage after a mean of 7.3 (SD 4.0) days ([Table 2](#tbl2){ref-type="table"}). The diagnostic tool was observed in the CT scan of 79% of the patients, in the contrast clyster in 11% of the patients and in only the clinical examination in 11% of the patients. The contrast clyster performed at postoperative day five detected three out of five (60%) ALs in the TD group. Two of the ALs were minor without any clinical sign and could be treated using antibiotics only. There was no difference in the time of detection of the AL for the TD (8.4 days) compared to the NTD group (6.9 days; p = 0.91). In the TD group, one (1/5) patient developing AL required surgical re-intervention compared to 14 (14/15) patients in the NTD group (p = 0.006). This patient in the TD group was not treated with open abdomen therapy compared to six (6/14) in the NTD group (p = 0.008) ([Table 3](#tbl3){ref-type="table"}).

An identified risk factor in univariate analysis for a higher leakage rate was ASA 4 (p = 0.02), whereas TDT was identified as a protective factor for AL (p = 0.007) ([Table 1](#tbl1){ref-type="table"}).

In the linear regression model of all potential risk factors, the only significant factor was TDT (p = 0.004) ([Table 4](#tbl4){ref-type="table"}).

3.2. Severity of anastomotic leakage {#sec3.2}
------------------------------------

The mean deficiency score of AL was 1.2 in TD compared to 1.7 in the NTD group (p = 0.24). The grade of complication of anastomotic leakage was significantly reduced in the TD group (e.g., Dindo ≧ 3b: 20.0% vs. 92.9%; p = 0.006), as shown in [Table 3](#tbl3){ref-type="table"}.

3.3. Medical complications {#sec3.3}
--------------------------

Other medical complications occurred in 63 (22.7%) patients and included mainly (90.5%) the urinary tract, wound infections or pneumonia and were treated locally or with antibiotics (Dindo-Clavien ≤2).

4. Discussion {#sec4}
=============

AL after colorectal surgery is one of the major complications that has a great effect on mortality. Various risk factors contributing to AL after rectal cancer surgery have been reported in the literature [@bib6], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], including old age, male gender, smoking, diabetes, cardiovascular disease, obesity, preoperative radiochemotherapy, air leak, prolonged operating time, and pelvic drainage.

The overall leak rate of 7.9% reported in our study is comparable to previously published studies, reporting leak rates ranging from 2.8 to 15% [@bib14], [@bib19], [@bib20], [@bib21].

Our study showed one significant risk factor for AL in the univariate analysis, with ASA 4 (p = 0.02) presenting a higher rate of AL, while the TDT has been found to be a preventive factor for AL (p = 0.007).

Comorbidities and patient performance are known factors that influence anastomotic healing [@bib22], [@bib23] and were confirmed in our study.

A comparison of patient demographics of the interventional TD group with the NTD group identified several significant differences:

The TD group showed higher rates in intraoperative endoscopic control of anastomosis (p = 0.001). Routinely used intraoperative colonoscopy to evaluate the anastomosis appears to have a beneficial effect in reducing the AL rates, although previously published data were only Level IV, and due to the small sample size, it was partially not significant and not very strong [@bib24], [@bib25].

The TD group showed a significant higher rate of stapled colorectal anastomosis (p = 0.004). In a Cochrane analysis 2012 [@bib26], Neutzling et al. demonstrated no difference in the AL between hand sewn and stapled anastomosis and confirmed previously published reviews [@bib27], [@bib28].

Considering the fact that AL was significantly reduced in the TD group compared to the NTD group (p = 0.007), the reduced hospital stay for patients with TDT could be easily explained.

The first report regarding the use of a TDT was published 17 years ago [@bib29] and showed a benefit for protective use in colorectal anastomosis [@bib9]. Following two published studies [@bib12], [@bib30], we confirmed the protective effect of the TDT, resulting in improved clinical outcomes of colorectal anastomosis in a more diverse study population, which included patients with preoperative radiotherapy, loop ileostomy and rectal resection for gynecological neoplasm.

In 2011, Xiao et al. published a single center prospective randomized trial of 398 patients with rectal cancer. Patients with TDT presented a lower incidence of AL and a lower rate of reoperation for symptomatic AL. TDT placement decreased the rectal resting pressure and was associated with an accelerated restoration of gastrointestinal peristalsis function, both of which might play a potential role in better outcomes. Nevertheless, this study excluded preoperative radiotherapy and, as stated by the authors, it appears to be biased on the basis of surgical skills.

Zhao et al. published in 2013 a single center prospective nonrandomized trial of 158 patients with rectal cancer. Patients who underwent a protective stoma procedure, emergency or palliative operation as well as patients who received preoperative chemo- or radiotherapy were excluded. This study also reported a lower anastomotic leakage and bleeding rate in patients where a TDT was placed, but failed to achieve significance due to the small sample size.

The results of these two studies are confirmed in our study. Multivariate analysis of potential risk factors for AL revealed TDT as the only significant factor. Furthermore, we demonstrated an advantage in the reduction of the severity of AL in patients with TDT. Patients suffering from AL with TDT developed significantly less severe complications. A potential explanation could be the earlier detection of AL by the routinely performed radiography with a contrast clyster on POD five in patients with a TDT only, although the difference between 7.0 days in the TD group compared to 9.1 days for the NTD group did not reach a level of significance. Furthermore, the routinely used contrast clyster identifies clinically silent AL and might contribute to a lower severity rate of AL, but is in contrast theoretic to the higher rate of AL by detecting silent AL. Moreover, the benefit of the TDT derives from its effect on the anal sphincter, resulting in partial incontinence for gas and liquids, which avoids the elevation of intraluminal pressure and therefore supports a better blood supply in the colon wall. Despite this benefit, the TDT cannot circumvent known risk factors of anastomotic healing, such as tension, on the anastomosis or limited blood supply. In cases of AL, the TDT appears to function as a target drainage, reducing the propagation of sepsis into the intrabdominal space. This effect results in a reduction of both reoperation and open abdomen treatment rates in cases of AL similarly to the observed results of Xiao et al.

Three patients (2.2%) mentioned discomfort or perianal pain and asked for drain removal before POD five. It seems obvious, that the TDT generates discomfort, but there is actually no data about this topic. Indeed, discomfort was not regularly measured in patients with TDT, but this question will be answered by an ongoing prospective clinical study at our department.

Our retrospective study demonstrates a significant reduction in the AL rate in colorectal anastomoses using a TDT for five days. In contrast to two recently published studies, this study does not exclude patients who received radiotherapy before the operation or patients with a loop ileostomy (n = 67; 24.2%). In addition, it is the first study to demonstrate a significant beneficial effect of this technique on the severity of AL and hospital stay. To investigate this effect, further prospective randomized trials are needed to confirm these.
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###### 

Demographic parameters comparing the NTD vs. TD group, significance (p \< 0.05) is indicated by an \*.

                               NTD              TD                                   
  ---------------------------- ---------------- ---------------- ------------ ------ -------------
  Patients                     103              42.6             139          57.4   
  Male gender                  58               56.3             81           58.3   0.79
  Age \[years\]                63.9 (SD 15.5)   63.2 (SD 13.4)   0.71                
  Neoplasm                     51               49.5             74           53.2   0.60
  Indication                                                                         0.49
   Elective                    72               69.9             105          75.5   
   Semi-elective               19               18.4             18           12.9   
   Emergency                   12               11.7             16           11.5   
  Bowel preparation                                                                  0.90
   Oral                        52               50.5             72           51.8   
   Rectal                      51               49.5             67           48.2   
  ASA                                                                                0.11
   1                           9                8.7              17           12.2   
   2                           45               43.7             75           54.0   
   3                           41               39.8             43           30.9   
   4                           8                7.8              4            2.9    
  Laparoscopic procedure       30               29.1             53           38.1   0.17
  Abdominal drain              82               79.6             115          82.7   0.62
  Endoscopic control           59               57.3             109          78.4   **0.001\***
  Loop ileostomy               22               21.4             41           29.5   0.18
  Resection                                                                          0.24
   Anterior                    56               54.4             67           48.2   
   Low anterior                31               30.1             38           27.3   
   Extended low anterior       16               15.5             34           24.5   
  Reconstruction                                                                     0.14
   E/E                         62               60.2             75           54.0   
   S/E                         35               34.0             61           43.9   
   S/S                         6                5.8              3            2.2    
  Stapled anastomosis          81               78.6             128          92.1   **0.004\***
  Delayed anastomosis          13               12.6             16           11.5   0.84
  Anastomotic leakage          14               13.6             5            3.6    **0.007\***
  Non surgical complications   23               22.3             31           22.3   1.0
  Hospital stay \[days\]       22.1 (SD 17.6)   17.6 (SD 12.5)   **0.02\***          
  Hospital mortality           3                2.9              0            0      0.08

###### 

Clinical parameters and risk factors for anastomotic leakage, significance (p \< 0.05) is indicated by an \*.

                           All patients   Anastomotic leakage               
  ------------------------ -------------- --------------------- ---- ------ -------------
  All patients             242            100                   19   7.9    
  Male gender              139            57.4                  8    5.8    0.23
  ASA                                                                       
  1                        26             10.7                  3    11.5   
  2                        120            49.6                  9    7.5    
  3                        84             34.7                  4    4.8    
  4                        12             5.0                   3    25.0   **0.02\***
  Indication                                                                0.83
   Elective                177            73.1                  13   7.3    
   Semi-elective           37             15.3                  3    8.1    
   Emergency               28             11.6                  3    10.7   
  Neoplasm                 125            51.7                  12   9.6    0.35
  Bowel preparation                                                         0.48
   Oral                    124            51.2                  8    6.5    
   Rectal                  118            48.8                  11   9.3    
  Laparoscopic procedure   83             34.3                  7    8.4    0.81
  Transanal drain          139            57.4                  5    3.6    **0.007\***
  Abdominal drain          197            81.4                  15   7.6    0.76
  Endoscopic control       168            69.4                  12   7.1    0.61
  Loop ileostomy           63             26.0                  4    6.3    0.79
  Resection                                                                 0.39
   Anterior                123            50.8                  8    6.5    
   Low anterior            69             28.5                  8    11.6   
   Extended low anterior   50             20.7                  3    6.0    
  Reconstruction                                                            0.62
   E/E                     137            56.5                  12   8.8    
   S/E                     96             39.7                  7    7.3    
   S/S                     9              3.7                   0    0      
  Stapled anastomosis      209            86.4                  17   8.1    1.0
  Other complications      54             22.3                  3    5.6    0.58

###### 

Difference between patients with AL for the NTD and TD groups, significance (p \< 0.05) is indicated by an \*.

                                   NTD (n = 14)   TD (n = 5)   p-value          
  -------------------------------- -------------- ------------ --------- ------ -------------
  Occurrence \[days\]              6.86           3.28         8.40      6.03   0.91
  Deficiency score                 1.71           0.73         1.2       0.45   0.24
  Dindo ≥ 3b \[%\]                 92.9           26.7         20.0      44.7   **0.006\***
  Abdominal vacuum therapy \[%\]   42.9           51.4         0         0      0.008\*

###### 

Linear regression analysis using the backwards method for anastomotic leakage, significance (p \< 0.05) is indicated by an \*.

                           Hazard ratio   95% confidence interval   p-value   
  ------------------------ -------------- ------------------------- --------- -------------
  Age                      −0.61          −0.003                    0.002     0.54
  Gender                   −1.37          0.171                     −0.115    0.17
  ASA                      −0.20          −0.060                    0.049     0.85
  Indication               1.28           −0.19                     0.088     0.20
  Neoplasm                 1.48           −0.017                    0.120     0.14
  Bowel preparation        −0.62          −0.096                    0.050     0.54
  Laparoscopic procedure   0.95           −0.040                    0.115     0.34
  Transanal drain          −2.90          −0.168                    −0.032    **0.004\***
  Abdominal drain          −0.41          −0.102                    0.067     0.68
  Endoscopic control       −0.46          −0.103                    0.064     0.65
  Loop ileostomy           −0.54          −0.111                    0.063     0.59
  Resection                0.50           −0.51                     0.086     0.62
  Reconstruction           −0.36          −0.045                    0.031     0.72
  Stapled anastomosis      −1.15          −0.166                    0.044     0.25
  Delayed anastomosis      −0.61          −0.176                    0.093     0.54
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